About
Ablative Solutions, Inc. is a medical technology company based in Wakefield, Massachusetts, founded in 2011. The company focuses on developing innovative renal denervation solutions to treat hypertension and related cardiovascular conditions. Their mission is to enhance patients' lives by delivering therapies that target the overactive sympathetic nervous system, which plays a role in various health issues, including hypertension and heart failure. The flagship product, the Peregrine System™, is an infusion catheter designed to deliver dehydrated alcohol to the renal artery area, facilitating a minimally invasive procedure to reduce high blood pressure. Ablative Solutions has conducted several clinical trials, including the TARGET BP OFF-MED and TARGET BP I trials, to assess the safety and efficacy of their product for treating uncontrolled hypertension. The company values integrity, teamwork, and innovation, and collaborates with partners like REV·1 Engineering to advance product development and clinical readiness.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2011
-
Annual Revenue $14588000
-
Total Funding $155262722
Location
301 Edgewater Pl, Wakefield, Massachusetts, United States, 01880-6217